Colgate Palmolive (CL) Common Equity (2009 - 2026)

Colgate Palmolive has reported Common Equity for 18 years, with the latest figure at $566.0 million in Q2 2026.

• On a quarterly basis, Common Equity fell 46.2% year-over-year to $566.0 million in Q2 2026; TTM through Jun 2026 was $566.0 million, a 46.2% decrease from a year earlier, with the FY2025 full-year figure at $365.0 million, down 32.9% from the prior year.
• Common Equity was $566.0 million for Q2 2026 at Colgate Palmolive, up from $486.0 million in the prior quarter.
• The five-year high for Common Equity was $1.2 billion in Q3 2025, with the low at $315.0 million in Q2 2023.
• Average Common Equity over 5 years is $675.9 million, with a median of $591.5 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Common Equity tumbled 61.44% in 2023, then soared 118.26% in 2025.
• Over 5 years, Common Equity stood at $806.0 million in 2022, then gained by 18.73% to $957.0 million in 2023, then sank by 43.16% to $544.0 million in 2024, then slumped by 32.9% to $365.0 million in 2025, then jumped by 55.07% to $566.0 million in 2026.
• The last three Common Equity figures came in at $566.0 million (Q2 2026), $486.0 million (Q1 2026), and $365.0 million (Q4 2025), per Business Quant data.